X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Molecular Biomedicine

期刊標題檢索 最新評論: I would like to ask how long it usually takes to receive feedback afte... (2026-01-12)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Molecular Biomedicine]您好,您是該頁面的第 10105 位訪客。

期刊簡介
期刊名稱Molecular Biomedicine Molecular Biomedicine

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
4.0
50 ratings
Rate

Reputation
4.8

Influence
2.8

Speed
7.1

期刊簡稱
ISSN2662-8651
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.102.3871.301
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q134 / 177
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q180 / 410

自引率 (2023-2024)3.20%自引率趨勢
掲載範囲
官方網站https://www.springer.com/journal/43556
在線稿件提交
開放訪問Yes
出版商Springer
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區Switzerland
發行頻率
創刊年0
每年文章數65每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP1790; USD2490; EUR2090; )
APC waiver:Check Notes
Other charges: No
Keywords: biomedicine、genetics、bioinformatics、molecular biology、gene editing
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYESCIQ123/320
CELL BIOLOGYESCIQ127/204
MEDICINE, RESEARCH & EXPERIMENTALESCIQ118/195
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2662-8651%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 10 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Molecular Biomedicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal for ImmunoTherapy of CancerH-index: 36

    CiteScore: 17.80
    Biomarker ResearchH-index: 0

    CiteScore: 15.30
    Cell Chemical BiologyH-index: 166

    CiteScore: 12.60
    Molecular OncologyH-index: 63

    CiteScore: 11.40
    VIROLOGICA SINICAH-index: 20

    CiteScore: 7.90
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINEH-index: 0

    CiteScore: 8.70
    Biotechnology JournalH-index: 70

    CiteScore: 6.10
    Frontiers in GeneticsH-index: 61

    CiteScore: 6.20
    Pharmacogenomics & Personalized MedicineH-index: 0

    CiteScore: 4.20
    Advances in Biological RegulationH-index: 0

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics530250
    Journal for ImmunoTherapy of Cancer148505
    Cell Chemical Biology83697
    Molecular Oncology63451
    Biotechnology Journal47445
    VIROLOGICA SINICA44497
    Biomarker Research41403
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE33403
    Advances in Biological Regulation18327
    Pharmacogenomics & Personalized Medicine17918
  •  

    Molecular Biomedicine Molecular Biomedicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Molecular Biomedicine] 的評論撰寫評論
作者: xiaoxiannv


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-01-12 13:57:35 評論於
I would like to ask how long it usually takes to receive feedback after the first round of revisions on an article. I have been in the "Editor Assigned" status for over a month after completing my revisions.
(0) 讚! | xiaoxiannv

作者: xiaoxiannv


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-01-12 13:54:26 評論於
I would like to ask how long it typically takes to receive feedback after the first revision of an article. It has been over a month since I completed the revision, and the status is still showing as "Editor Assigned."
(0) 讚! | xiaoxiannv

作者: 黑色creation


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-12-08 15:46:02 評論於
Real-time inflation has already exceeded 10%, and it should be around 12 or 13 points next year.
(0) 讚! | 黑色creation

作者: 黑色creation


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-12-08 15:43:36 評論於
Soon, the submission to acceptance process is relatively faster compared to other journals, taking a total of 5 months.
(0) 讚! | 黑色creation

作者: accept


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-12-04 13:51:27 評論於
Excuse me, is the initial decision made quickly?
(0) 讚! | accept

作者: 黑色creation


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-25 10:25:48 評論於
This impact factor, like riding a rocket, plus the presence of academicians, could it be the next STTT?
(0) 讚! | 黑色creation

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Molecular Biomedicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*